PharmacoEconomics Journal Issues Research Articles in Vol. 40, No. 5
May 12, 2022
May 12, 2022
BASEL, Switzerland, May 12 -- PharmacoEconomics, a peer-reviewed journal that says it features application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes, published research articles on the following topics in its Vol. 40, No. 5 edition:
Review Article:
* Mogamulizumab for Previously Treated Mycosis Fungoides and Sezary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Syst . . .
Review Article:
* Mogamulizumab for Previously Treated Mycosis Fungoides and Sezary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Syst . . .